TPE for Autoimmune & Chronic Inflammatory Conditions
We help people with a diagnosed autoimmune or inflammatory condition who have plateaued on standard treatment by offering plasma exchange with autoantibody and inflammation testing before and after, so they can see what is changing in their own labs.
Part of Blood Rehabilitation:RemoveRestoreSupport
- 8090 N. 85th Way, Suite 100, Scottsdale, AZ 85258
- (623) 294-5577
- Monday to Friday, 9 a.m. to 5 p.m.

Want this measured, not just discussed?
The scope of the problem
Autoimmune disease is common and, in aggregate, underappreciated as a category: systemic lupus erythematosus alone is estimated to affect approximately 72.8 per 100,000 U.S. adults — roughly 200,000 people nationally — according to a CDC National Lupus Registry meta-analysis.¹ Guillain-Barré syndrome, by contrast, is rare but acute, with an estimated annual incidence of roughly 1 to 2 cases per 100,000 people. Patients researching TPE for a diagnosed autoimmune or inflammatory condition are usually working alongside a specialist already, often after standard treatment has plateaued.
How it's treated today
Standard treatment for most autoimmune and chronic inflammatory conditions centers on immunosuppressive or immunomodulatory medication — corticosteroids, disease-modifying agents, and increasingly targeted biologics — managed by a rheumatologist, neurologist, or other specialist.
The unmet need
A meaningful share of patients plateau on standard treatment, cannot tolerate the medications at an effective dose, or continue to have circulating autoantibodies and immune complexes driving disease activity despite treatment. TPE's established role, where recognized, is specifically as an adjunct for this population — not a first-line replacement for standard care.
Where TPE may help — established vs. exploratory
TPE has a defined, physician-recognized role for certain diagnoses under the American Society for Apheresis (ASFA) clinical application categories, the same evidence-graded framework used by hospital-based apheresis units nationally.² Established uses and exploratory interest have different levels of evidence.
- Established / ASFA-categorized indications — e.g. Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy — conditions where TPE has a defined, physician-referral-driven clinical role.²
This track tends to fit patients who...
- Have a diagnosed autoimmune or inflammatory condition and are exploring TPE alongside their existing treatment plan
- Have plateaued on standard treatment and are researching adjunctive options with their specialist
- Are working directly with a referring physician, or want help coordinating with one
How we work with your existing care
If your care team is referring you here, see our Physician & Provider Referrals page for the fast-track process.
References
- Izmirly PM, Parton H, Wang L, et al. Prevalence of Systemic Lupus Erythematosus in the United States: Estimates From a Meta-Analysis of the Centers for Disease Control and Prevention National Lupus Registries. Arthritis Rheumatol. 2021;73(6):991-996.
- Connelly-Smith L, et al. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special Issue. J Clin Apher. 2023;38(2).
This page describes general information about therapeutic plasma exchange and is not medical advice. TPE is not intended to diagnose, treat, cure, or prevent any disease. Patients with a diagnosed condition should coordinate care with their treating physician or specialist; some indications require a physician referral.

Questions worth asking any clinic, including ours.
Before you decide, ask us these. We’ll answer them plainly.
- What is the evidence for this use of TPE, and how strong is it?
- What will my Focused panel measure, what would an Expanded panel add, and how will we know what changed?
- What are the risks, and who should not have this procedure?
- What will it cost in total? (The Focused panel is included; the Expanded panel is an additional fee.)
- How will my own physician or clinician be kept informed?
Call us or send a request online, and our clinical team will answer your questions and set up a consultation.
Visit or call the clinic
Blood Rehabilitation Centers, Scottsdale, Arizona. Call us or send a request online, and our clinical team will answer your questions and set up a consultation.
Call (623) 294-5577- 8090 N. 85th Way, Suite 100, Scottsdale, AZ 85258
- Monday to Friday, 9 a.m. to 5 p.m.
What would you like to understand?
Browse all pages
- Home
- Blood Rehabilitation
- How We Prove It
- Programs
- The Vitality Cascade
- Membership
- TPE / Plasmapheresis
- TPE Fees & Packages
- How ClearCycle™ TPE Works
- The Evidence Behind TPE
- TPE Patient Experience
- eBoo
- EBO2 Fees & Packages
- How EBO2 Works
- EBO2 Patient Experience
- Safety & Standards
- Dr. David George
- Team
- For referring clinicians
- Contact Us in Scottsdale
- Frequently Asked Questions
- Privacy
- Terms & Conditions
- Cookie Policy
- Accessibility
- TPE for Biological Age
- TPE for Autoimmune & Chronic Inflammatory Conditions
- TPE for Cardiovascular Health
- TPE for Brain Health & Cognitive Function
- TPE for Environmental Exposure: Mold, Microplastics & Environmental Toxins
- TPE for Women’s Health
- Cardiovascular Health Program
- Biological Age
- Brain Health
- Autoimmune
- Environmental Exposure Program
- Women’s Health
- Performance Blood Health
- AMBAR trial summary